Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Human Platelet Lysate for Lateral Epicondylitis
NCT01668862Phase 2Unknown
- Sponsor
- Kasiak Research Pvt Ltd.
- Start
- Mar 2012
- Primary completion
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous human platelet lysate in Lateral Epicondylitis (LET) (2 arms), sponsored by Kasiak Research Pvt Ltd. Primary endpoint: Visual Analog Score at Month 3. Status: unknown.
02
Drugs
autologous human platelet lysate
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT01668862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668862.